Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123158482 | 12315848 | 2 | F | 2016 | 20160727 | 20160428 | 20160803 | EXP | US-UNITED THERAPEUTICS-UNT-2016-003189 | UNITED THERAPEUTICS | 72.09 | YR | F | Y | 51.70000 | KG | 20160803 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123158482 | 12315848 | 1 | PS | REMODULIN | TREPROSTINIL | 1 | Subcutaneous | 0.037 ?G/KG, CONTINUING | 2100500 | 21272 | .037 | UG/KG | INJECTION | ||||||
| 123158482 | 12315848 | 2 | C | LETAIRIS | AMBRISENTAN | 1 | 0 | ||||||||||||
| 123158482 | 12315848 | 3 | C | ADCIRCA | TADALAFIL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123158482 | 12315848 | 1 | Pulmonary hypertension |
| 123158482 | 12315848 | 2 | Product used for unknown indication |
| 123158482 | 12315848 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123158482 | 12315848 | OT |
| 123158482 | 12315848 | DE |
| 123158482 | 12315848 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123158482 | 12315848 | Acute respiratory failure | |
| 123158482 | 12315848 | Ascites | |
| 123158482 | 12315848 | Cholelithiasis | |
| 123158482 | 12315848 | Constipation | |
| 123158482 | 12315848 | Cystitis haemorrhagic | |
| 123158482 | 12315848 | Diarrhoea | |
| 123158482 | 12315848 | Diffuse large B-cell lymphoma | |
| 123158482 | 12315848 | Fluid overload | |
| 123158482 | 12315848 | Fungal sepsis | |
| 123158482 | 12315848 | Gastritis | |
| 123158482 | 12315848 | Haematemesis | |
| 123158482 | 12315848 | Hypophagia | |
| 123158482 | 12315848 | Neutropenia | |
| 123158482 | 12315848 | Pneumonia aspiration | |
| 123158482 | 12315848 | Pulmonary hypertension | |
| 123158482 | 12315848 | Pulmonary oedema | |
| 123158482 | 12315848 | Right ventricular failure | |
| 123158482 | 12315848 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123158482 | 12315848 | 1 | 20131219 | 0 |